Search in:

OncoTargets and Therapy Volume 5, 2012 - Issue

Submit an article Journal homepage

Open access

103

Views

CrossRef citations to date

Altmetric

Review

Denosumab: a new option in the treatment of bone metastases from urological cancers

Takeshi YuasaDepartment of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, JapanCorrespondence[email protected]

Shinya YamamotoDepartment of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan

Shinji UrakamiDepartment of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan

Iwao FukuiDepartment of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan

Junji YoneseDepartment of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Tokyo, Japan

Pages 221-229 | Published online: 21 Sep 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Mohammed Tanjimur Rahman, Youzhi Kaung, Logan Shannon, Charlie Androjna, Nima Sharifi & Vinod Labhasetwar. (2023) Nanoparticle-mediated synergistic drug combination for treating bone metastasis. Journal of Controlled Release 357, pages 498-510.
Crossref

Ahmed Samir Abdelhafiz, Mona Wassef & Mohamed Alorabi. (2020) Pleural empyema due to Salmonella in a patient with bronchogenic carcinoma: the first case report from a cancer hospital in Egypt. Access Microbiology 2:9.
Crossref

Sivakumar Vijayaraghavalu, Yue Gao, Mohammed Tanjimur Rahman, Richard Rozic, Nima Sharifi, Ronald J. Midura & Vinod Labhasetwar. (2020) Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis. Biomaterials 227, pages 119558.
Crossref

Zach Pennington, A. Karim Ahmed & Daniel M. Sciubba. 2020. Central Nervous System Metastases. Central Nervous System Metastases 583 601 .

Sebastian Lux, Nicolas Lobos, Carolyne Lespay-Rebolledo, Edison Salas-Huenuleo, Marcelo J Kogan, Christian Flores, Mauricio Pinto, Alejandro Hernandez, Teresa Pelissier & Luis Constandil. (2019) The antinociceptive effect of resveratrol in bone cancer pain is inhibited by the Silent Information Regulator 1 inhibitor selisistat. Journal of Pharmacy and Pharmacology 71:5, pages 816-825.
Crossref

Hiroshi Masuda, Kanya Kaga, Masahiko Inahara, Kazuhiro Araki, Satoko Kojima, Yukio Naya & Makoto Takano. (2017) Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate Cancer. Urology Case Reports 13, pages 63-65.
Crossref

Mutsushi Yamasaki, Takeshi Yuasa, Sho Uehara, Yasuhisa Fujii, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui & Junji Yonese. (2016) Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab. International Journal of Clinical Oncology 21:6, pages 1191-1195.
Crossref

Navdeep Dahiya, Anjan Khadka, A.K. Sharma, A.K. Gupta, Nishith Singh & D.B.S. Brashier. (2015) Denosumab: A bone antiresorptive drug. Medical Journal Armed Forces India 71:1, pages 71-75.
Crossref

Giovanni Luca Gravina, Monica Tortoreto, Andrea Mancini, Alessandro Addis, Ernesto Di Cesare, Andrea Lenzi, Yosef Landesman, Dilara McCauley, Michael Kauffman, Sharon Shacham, Nadia Zaffaroni & Claudio Festuccia. (2014) XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa). Journal of Hematology & Oncology 7:1.
Crossref

E. David Crawford, Nelson N. Stone, Evan Y. Yu, Phillip J. Koo, Stephen J. Freedland, Susan F. Slovin, Leonard G. Gomella, E. Roy Berger, Thomas E. Keane, Paul Sieber, Neal D. Shore, Daniel P. Petrylak, E. Roy Berger, Raoul S. Concepcion, E. David Crawford, Stephen Freedland, Jorge A. Garcia, Leonard G. Gomella, Larry Karsh, Thomas E. Keane, Phillip J. Koo, Daniel P. Petrylak, Neal Shore, Paul Sieber, Susan F. Slovin, Nelson N. Stone & Evan Y. Yu. (2014) Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer. Urology 83:3, pages 664-669.
Crossref

Kirsty Balachandran & Sanjay Popat. (2013) Endocrine manifestations of malignancy. Medicine 41:10, pages 570-572.
Crossref

F. Milat, S. Goh, L.U. Gani, C. Suriadi, M.T. Gillespie, P.J. Fuller, H.J. Teede, A.H. Strickland & C.A. Allan. (2013) Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer. Bone 55:2, pages 305-308.
Crossref

Robert P. Loewe. (2013) Combinational usage of next generation sequencing and qPCR for the analysis of tumor samples. Methods 59:1, pages 126-131.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Denosumab: a new option in the treatment of bone metastases from urological cancers

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Denosumab: a new option in the treatment of bone metastases from urological cancers

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date